Cigna Corporation (CI) Given Consensus Rating of “Buy” by Analysts
Cigna Corporation (NYSE:CI) has been assigned a consensus recommendation of “Buy” from the seventeen brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $190.27.
A number of equities analysts recently weighed in on CI shares. Bank of America Corporation lifted their target price on shares of Cigna Corporation from $193.00 to $198.00 and gave the stock a “buy” rating in a research note on Friday, June 23rd. ValuEngine downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Citigroup Inc. lifted their target price on shares of Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Jefferies Group LLC reissued a “buy” rating and set a $190.00 target price (down previously from $199.00) on shares of Cigna Corporation in a research note on Friday, August 4th. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $185.00 target price on shares of Cigna Corporation in a research note on Wednesday, August 9th.
In other news, Chairman Isaiah Harris, Jr. sold 247 shares of Cigna Corporation stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director William D. Zollars sold 1,232 shares of Cigna Corporation stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Insiders have sold 70,653 shares of company stock valued at $12,437,684 over the last quarter. Corporate insiders own 1.30% of the company’s stock.
Cigna Corporation (NYSE:CI) traded down 0.60% during mid-day trading on Wednesday, reaching $186.95. 1,321,009 shares of the company’s stock were exchanged. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $193.00. The firm has a market cap of $47.07 billion, a price-to-earnings ratio of 21.56 and a beta of 0.43. The stock has a 50-day moving average of $184.54 and a 200-day moving average of $169.60.
Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.98 earnings per share. Analysts anticipate that Cigna Corporation will post $10.03 earnings per share for the current year.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.